Aktiesnakken — Maj 2011
-
ja det kender jeg godt til
-
synes ikke jeg var informeret
-
jeg har haft så travl, men bliver mere aktiv nu med analyserne
-
jeg stoler 300% på dig solsenitsyn
-
hvad baserer de q4 på? jeg tror det samme, men er overrasket over at de vil så langt hen?
-
walldenstrøms er det ikke først i 2013?
-
det er da mere cll second line?
-
-
prøv at se pipelinen længere nede
-
-
direkte link
-
We expect very good results later this year in both Diffuse Large B-Cell Lymphoma (in combi with chemo) and Waldenstrom’s Disease will confirmArzerra’s superiority in Non-Hodgkin like diseases. Results to be presented at ASH. Furthermore, statistics s
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind